LQDA Margin operasi Liquidia Corporation

Liquidia Technologies (LQDA) - logo korporat

The business stability of Liquidia Corporation (LQDA) is limited by its dependence on external supply chains and geopolitical risks. The operating margin reflects profit dynamics, where 47.10 is recorded as the baseline value. While the company's growth relies on the commercialization of Treprostinil and patent successes, its critical concentration in a single therapeutic area necessitates an urgent portfolio expansion to mitigate overall risks.

LQDA: Rentabilitas dodolan miturut bathi operasi liquidia.com 04.07.2022 - 20.11.2026

Rincian analitis lan laporan data perusahaan Liquidia (LQDA)

Pambiji fundamental perusahaan:Liquidia Inc., LQDA
Produk dadi liquidia.com

Operating margin determines the share of profit from core operations relative to total revenue, serving as a fundamental indicator of cost management efficiency before accounting for financial and tax obligations. By analyzing the operating margin timeline, an investor will see Liquidia Corporation (LQDA) transition toward profitability following the resolution of legal disputes and the scaling of Yutrepia sales within the pulmonary hypertension therapy market.

Analisis perusahaan pesaing

Rentabilitas operasi haleon.com|Rentabilitas operasi KVUE|Rentabilitas operasi Verona Pharma (VRNA)|Jyong Biotech (MENS) - Tingkat bathi adhedhasar bathi operasi|Margin operasi LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Rentabilitas operasi|PRGO - Rentabilitas operasi|Alvotech Corp (ALVO) - Margin dodolan operasi|Galapagos N.V. (GLPG) - Rentabilitas operasi|anipharmaceuticals.com - Tingkat bathi operasi|Margin dodolan operasi MNKD|AMPH: Tingkat bathi operasi|Rentabilitas operasi pacira.com (PCRX)|Margin operasi ARS Pharma (SPRY)|Theravance Biopharma - Margin dodolan operasi|Rasio bathi operasi AQST (Aquestive Therapeutics)|SCPH: Margin dodolan operasi|Rentabilitas dodolan operasi Tectonic Therapeutic|TNXP: Margin operasi|SXT China (SXTC) - Margin operasi|Rentabilitas operasi eupraxiapharma.com|BioHarvest Sciences (BHST) - Rentabilitas kegiatan operasi|Rentabilitas operasi Invizyne (EXOZ)|ORMP - Rentabilitas dodolan operasi|Margin operasi ENTX (Entera Bio)|Tingkat bathi adhedhasar bathi operasi MindWalk Therapeutics|ABVC: Margin dodolan operasi|CPIX - Margin operasi|QNTM (Quantum BioPharma) - Margin dodolan operasi|Margin bathi operasi FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Margin operasi|Margin operasi ranitherapeutics.com|Rentabilitas operasi Synergy CHC Corp. (SNYR)|Rallybio Corp - Rentabilitas dodolan miturut bathi operasi|lexariabioscience.com - Margin dodolan operasi|Margin operasi Pulmatrix Inc PULM|Pheton Holdings - Margin operasi|Margin bathi operasi APM|Lyra Therapeutics, Inc. (LYRA) - Rentabilitas operasi|Rentabilitas dodolan operasi Impact BioMedical, Inc. (IBO)|Rentabilitas operasi TNF Pharma|YCBD: Tingkat bathi operasi|Margin operasi PRFX|CYTO - Rentabilitas dodolan operasi|Rentabilitas operasi Lipella LIPO|Rasio bathi operasi OPTN (OptiNose, Inc.)|PIRS - Rentabilitas operasi|Procaps (PROC) - Margin dodolan operasi|PTPI: Margin operasi|Qilian International (QLI) - Margin operasi|Rentabilitas operasi Acelyrin, Inc.|Margin operasi TFF Pharmaceuticals, Inc.